AU8188187A - Viral vector and recombinant DNA coding, in particular, for the p25 protein of the virus that is a causal agent of aids, infected cell culture, protein obtained, vaccine and antibodies obtained - Google Patents

Viral vector and recombinant DNA coding, in particular, for the p25 protein of the virus that is a causal agent of aids, infected cell culture, protein obtained, vaccine and antibodies obtained

Info

Publication number
AU8188187A
AU8188187A AU81881/87A AU8188187A AU8188187A AU 8188187 A AU8188187 A AU 8188187A AU 81881/87 A AU81881/87 A AU 81881/87A AU 8188187 A AU8188187 A AU 8188187A AU 8188187 A AU8188187 A AU 8188187A
Authority
AU
Australia
Prior art keywords
protein
virus
aids
viral vector
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU81881/87A
Other versions
AU604791B2 (en
Inventor
Marc Girard
Jean-Claude Gluckmann
Marie-Paule Kieny
Jean-Pierre Lecocq
Luc Montagnier
Guy Rautmann
Patrick Salmon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Institut Pasteur de Lille
Original Assignee
Transgene SA
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA, Institut Pasteur de Lille filed Critical Transgene SA
Publication of AU8188187A publication Critical patent/AU8188187A/en
Application granted granted Critical
Publication of AU604791B2 publication Critical patent/AU604791B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Viral vector comprising at least: - a part of the genome of a vector virus, - the complete gag gene or one of its subfragments, especially a gene coding for the p25 protein or a gene coding for the p18 protein of the HIV virus responsible for AIDS, - and the elements ensuring the expression of this protein in eukaryote cells in a culture.
AU81881/87A 1986-12-01 1987-11-27 Viral vector and recombinant DNA coding, in particular, for the p25 protein of the virus that is a causal agent of aids, infected cell culture, protein obtained, vaccine and antibodies obtained Ceased AU604791B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8616787A FR2607518B1 (en) 1986-12-01 1986-12-01 VIRAL VECTOR AND RECOMBINANT DNA ENCODING PROTEIN P25 OF THE VIRUS CAUSAL AGENT OF THE S.I.D.A., INFECTED CELL CULTURE, PROTEIN OBTAINED, VACCINE AND ANTIBODIES OBTAINED
FR8616787 1986-12-01

Publications (2)

Publication Number Publication Date
AU8188187A true AU8188187A (en) 1988-06-02
AU604791B2 AU604791B2 (en) 1991-01-03

Family

ID=9341436

Family Applications (1)

Application Number Title Priority Date Filing Date
AU81881/87A Ceased AU604791B2 (en) 1986-12-01 1987-11-27 Viral vector and recombinant DNA coding, in particular, for the p25 protein of the virus that is a causal agent of aids, infected cell culture, protein obtained, vaccine and antibodies obtained

Country Status (9)

Country Link
EP (1) EP0276591B1 (en)
JP (1) JPS63254983A (en)
KR (1) KR880007728A (en)
AT (1) ATE103934T1 (en)
AU (1) AU604791B2 (en)
DE (1) DE3789545T2 (en)
DK (1) DK631387A (en)
FR (1) FR2607518B1 (en)
PT (1) PT86234B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2617715B1 (en) * 1987-07-07 1990-08-31 Transgene Sa VIRAL VECTOR AND RECOMBINANT DNA ENCODING FOR ONE OR MORE SURFACE PROTEINS (HA AND / OR F) OF A MORBILLIVIRUS, INFECTED CELL CULTURE, PROTEINS OBTAINED, VACCINE AND ANTIBODIES OBTAINED
EP0361749B1 (en) * 1988-09-27 1995-02-08 Dana Farber Cancer Institute A vector comprising a replication competent HIV-I provirus and a heterologous gene
FR2640877A1 (en) * 1988-12-06 1990-06-29 Centre Nat Rech Scient
US5232829A (en) * 1989-09-29 1993-08-03 Hoffmann-La Roche Inc. Detection of chlamydia trachomatis by polymerase chain reaction using biotin labelled lina primers and capture probes
JP2002125687A (en) * 2000-10-30 2002-05-08 Tosoh Corp Oligonucleotide for detecting hiv-1 and method for detecting the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE109512T1 (en) * 1985-04-08 1994-08-15 Genetic Systems Corp EXPRESSION AND DIAGNOSIS USING GAG-ENCODED PEPTIDES IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV.

Also Published As

Publication number Publication date
PT86234A (en) 1987-12-01
FR2607518A1 (en) 1988-06-03
AU604791B2 (en) 1991-01-03
EP0276591A2 (en) 1988-08-03
KR880007728A (en) 1988-08-29
EP0276591A3 (en) 1988-10-05
DK631387D0 (en) 1987-12-01
DE3789545T2 (en) 1994-08-25
FR2607518B1 (en) 1989-10-20
PT86234B (en) 1990-11-07
EP0276591B1 (en) 1994-04-06
DK631387A (en) 1988-06-02
ATE103934T1 (en) 1994-04-15
JPS63254983A (en) 1988-10-21
DE3789545D1 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
ATE291632T1 (en) LENTIVIRUS-BASED GENE TRANSFER VECTORS
EP0702716A4 (en) Ribozyme gene therapy for hiv infection and aids
DE69033896T2 (en) GENE TECHNOLOGICAL PRODUCTION OF VACCINE AGENTS AGAINST AIDS AND OTHER RETROVIRAL DISEASES
ATE366314T1 (en) INFECTIOUS RNA VIRUS CLONES, VACCINES AND DERIVED DIAGNOSTIC ASSAY
AU7234987A (en) Viral vector coding for a glycoprotein of the virus responsible for a.i.d.s., vaccine and antibody
AU571128B2 (en) Expression of immunologically reactive aids viral protein
EP0216564A3 (en) Infectious recombinant virus, vaccines containing said virus for feline leukemia, and methods for the production thereof
AU630861B2 (en) Recombinant hiv-2 polypeptides
AU8188187A (en) Viral vector and recombinant DNA coding, in particular, for the p25 protein of the virus that is a causal agent of aids, infected cell culture, protein obtained, vaccine and antibodies obtained
FR2600079B1 (en) VIRAL VECTOR AND RECOMBINANT DNA ENCODING PROTEIN F OF THE VIRUS CAUSAL AGENT OF THE S.I.D.A, CELL CULTURE INFECTED WITH THIS VECTOR, PROCESS FOR PREPARING THE PROTEIN, OBTAINED PROTEIN, VACCINE AND ANTIBODIES OBTAINED
DK498387A (en) Viral DNA SEQUENCE
AP1561A (en) Use of non-cytolytic retrovirus as vaccines for the treatment of HIV infection.
WO2003035849A3 (en) Methods for gene transfer using pseudotyped lentiviruses